Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pyrithiamine pyrophosphate is a synthetic derivative of pyrithiamine in which a pyrophosphate group is attached to the molecule. It acts as an antimicrobial agent and is structurally related to thiamine (vitamin B1). Pyrithiamine itself is known as an inhibitor of thiamine metabolism and can induce neurological symptoms similar to Wernicke-Korsakoff syndrome in animal models. The pyrophosphate form mimics thiamine pyrophosphate (TPP), the active coenzyme form of vitamin B1, but instead acts as an antagonist at TPP riboswitches found in bacteria and other organisms. By binding these riboswitches, it downregulates genes involved in thiamine metabolism and transport[2][3][7]. This mechanism underlies its antimicrobial activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pyrithiamine pyrophosphate.